Researchers have discovered how an active component of green tea called epigallocatechen gallate (EGCG) disrupts the metabolism of pancreatic cancer cells. They found that ECGC suppresses the expression of lactate dehydrogenase A, a critical enzyme in cancer cell metabolism. This finding adds to numerous previous studies that have suggested green tea and its extracts may provide suitable treatment for cancer. Metabolomics, April 2014